{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:11:22Z","timestamp":1793729482283,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.leukres.2021.106672","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T02:41:03Z","timestamp":1627094463000},"page":"106672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Autophagic degradation of NOXA underlies stromal cell-mediated resistance to proteasome inhibitors in mantle cell lymphoma"],"prefix":"10.1016","volume":"111","author":[{"given":"Yoshiaki","family":"Kuroda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehisa","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-6418","authenticated-orcid":false,"given":"Yusuke","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2021.106672_bib0005","doi-asserted-by":"crossref","first-page":"103038","DOI":"10.1016\/j.critrevonc.2020.103038","article-title":"Mantle cell lymphoma","volume":"153","author":"Cortelazzo","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.leukres.2021.106672_bib0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40164-019-0126-0","article-title":"Mantle cell lymphoma and its management: where are we now?","volume":"8","author":"Ladha","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2021.106672_bib0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11864-019-0684-8","article-title":"Leukemic non-nodal mantle cell lymphoma: diagnosis and treatment","volume":"20","author":"Jain","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.leukres.2021.106672_bib0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2017-04-776740","article-title":"SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma","volume":"130","author":"Balsas","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106672_bib0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood-2018-05-851667","article-title":"Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma","volume":"133","author":"Mohanty","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106672_bib0030","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S1470-2045(18)30743-5","article-title":"Bortezomib-based chemotherapy in mantle cell lymphoma","volume":"19","author":"Rule","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.leukres.2021.106672_bib0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pharmtox-010919-023603","article-title":"Proteasome inhibitor drugs","volume":"60","author":"Fricker","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.leukres.2021.106672_bib0040","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1073\/pnas.0807611106","article-title":"ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells","volume":"106","author":"Wanga","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.leukres.2021.106672_bib0045","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/1078-0432.CCR-10-3367","article-title":"Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma","volume":"17","author":"Weniger","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2021.106672_bib0050","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1038\/cddis.2013.552","article-title":"Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles\u2019 heel in mantle cell lymphoma","volume":"5","author":"Dengler","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.leukres.2021.106672_bib0055","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bbamcr.2018.05.007","article-title":"Autophagy regulates apoptosis by targeting NOXA for degradation","volume":"1865","author":"Wang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res"},{"key":"10.1016\/j.leukres.2021.106672_bib0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13045-018-0657-6","article-title":"Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA","volume":"11","author":"Heine","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2021.106672_bib0065","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1038\/bcj.2013.66","article-title":"Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma","volume":"3","author":"Hiraoka","year":"2013","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2021.106672_bib0070","doi-asserted-by":"crossref","first-page":"e90675","DOI":"10.1371\/journal.pone.0090675","article-title":"Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies","volume":"9","author":"Hiraoka","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2021.106672_bib0075","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1128\/MCB.25.12.5183-5195.2005","article-title":"Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential","volume":"25","author":"Mori","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.leukres.2021.106672_bib0080","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood-2002-04-1268","article-title":"Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells","volume":"101","author":"Kawano","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106672_bib0085","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4049\/jimmunol.0803183","article-title":"Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis","volume":"183","author":"Yoon","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2021.106672_bib0090","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41375-020-01035-x","article-title":"Bone marrow stromal cell-mediated degradation of CD20 leads to primary rituximab resistance in mantle cell lymphoma","volume":"35","author":"Kuroda","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2021.106672_bib0095","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1111\/bjh.16378","article-title":"A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma","volume":"188","author":"Lee","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2021.106672_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2019.11.006","article-title":"To eat or to die: deciphering selective forms of autophagy","volume":"45","author":"Abdrakhmanov","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.leukres.2021.106672_bib0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/cells8020103","article-title":"Therapeutic modulation of autophagy in leukaemia and lymphoma","volume":"8","author":"Djavaheri-Mergny","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.leukres.2021.106672_bib0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jnci\/djx236","article-title":"Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition","volume":"110","author":"Mitchell","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.leukres.2021.106672_bib0115","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1200\/JCO.2006.07.9665","article-title":"Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma","volume":"24","author":"Fisher","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2021.106672_bib0120","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S1470-2045(18)30685-5","volume":"19","author":"Robak","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.leukres.2021.106672_bib0125","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1158\/0008-5472.CAN-16-0595","article-title":"TG2 and NF-\u03baB signaling coordinates the survival of mantle cell lymphoma cells via IL6-mediated autophagy","volume":"76","author":"Zhang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2021.106672_bib0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/15548627.2016.1271516","article-title":"Tampering with cancer chemoresistance by targeting the TGM2-IL6-autophagy regulatory network","volume":"13","author":"Zhang","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.leukres.2021.106672_bib0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cas.14698","article-title":"AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells","volume":"112","author":"Koyama","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2021.106672_bib0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjh.12266","article-title":"A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma","volume":"161","author":"Voorhees","year":"2013","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:24Z","timestamp":1758934884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621001739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"alternative-id":["S0145212621001739"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106672","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagic degradation of NOXA underlies stromal cell-mediated resistance to proteasome inhibitors in mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106672"}}